Navigation Links
Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow -

processes and pathways - a disruption of homeostasis.

Dr. Richard Rosenbloom EVP/COO Quigley Pharma, Inc. stated, "We are encouraged by these and previous results and are looking forward to subjecting the compound to more rigorous tests to support eventual commercialization."

About The Study

The study results demonstrated a correlation to the levels of serum IL-6 and the degree of cachexia. Mice responding to QR-443 treatment had much lower levels of serum IL-6 which correlated with reduced cachexia, compared to non responders and the control population who had elevated IL-6 and dramatic weight loss. These findings are in agreement with several previous studies demonstrating the increased presence of IL-6 in the etiology of cachexia and other diseases related to inflammation.

The purpose of the study was to replicate positive oral dose response trials in BALB/C mice as well as to investigate the possible relationship of the levels of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) cytokines which have been associated with the severity and progression of cachexia. In this experiment a larger group of mice was used, their weight being recorded and blood being drawn prior to the onset of cachexia and then at the peak of cachexia which marked the end of the experiment. There was no correlation between the levels of TNF-alpha and the severity of cachexia and levels of IFN-gamma were lower than the detectable assay level.

The Quigley Corporation makes no representation that the U.S. Food and Drug Administration or any other regulatory agency will allow the aforementioned Compound to be tested in humans or marketed. Furthermore, no claim is made that the potential medicine discussed here is safe, effective, or approved by the Food and Drug Administration.

About The Quigley Corporation

The Quigley Corporation is a diversified natural health medical science company. Its Cold Reme
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
9. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
10. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Post Your Comments:
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech Ltd. ... of biopharmaceutical products in China ... subsidiary company of Sinovac, obtained the Certificate of ... from the China State and Food Administration (CFDA) ... production plants, and its Changping filing and packaging ...
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 33SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Antigua (AICASA) has signed an articulation agreement with ... their students to study abroad in Antigua. ... three college credits after participating in a cell biology ... an articulation agreement with American University of Antigua ...
(Date:5/24/2013)... recommended well-child visits had up to twice the risk ... their visits, according to a study published today in ... study included more than 20,000 children enrolled at Group ... asthma and heart disease were even more likely to ... study. In fact, children with chronic conditions who ...
(Date:5/24/2013)... New research presented today shows that formation of new ... for its importance in learning and remembering - could ... of existing brain circuits. Drs. Paul Frankland and ... in Toronto, argue this reorganization could have the positive ... increasing capacity for new learning. These results were ...
(Date:5/24/2013)... , , THURSDAY, May 23 (HealthDay News) -- Type 2 ... signs of serious complications seen just a few years ... the latest results, it seems like type 2 is ... senior vice president of medical affairs and community information ... and it appears to be at a more significant ...
(Date:5/24/2013)... MonaVie announces the appointment of Mauricio Patrocinio, vice ... the Ethics Board of ABEVD (Brazilian Association of Direct Sales ... this council and will do my best to promote and ... Patrocinio. , The direct selling industry is booming in Brazil ... selling industry has, for decades, helped improve the lives of ...
Breaking Medicine News(10 mins):Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2
... of Vertebral Subluxation Research (JVSR), suggests that chiropractic ... from learning disabilities and dyslexia.// ,The research ... president of the Swiss Chiropractic Pediatric Association, who ... learning and behavioral disorders. ,'This review ...
... Ranchi: Doctors in Jharkhand who were appointed on contract went ... ,Around 2,000 doctors were appointed three years ago on ... are now demanding that their job be regularised. ... Secretary M.K. Mandal on Monday, but they failed to reach ...
... If you ask about her child, Sita Devi's eyes well ... died in her arms. Although she managed to take her ... Hospital, it was too late. ,'Still we tried our ... was a case of severe malnutrition. 'But the child had ...
... novel study has indicated the benefits of tomato and broccoli ... present in both the vegetables, are a great blessing in ... than in isolation. ,It is estimated that ... prostate cancer, making it the most notorious of male cancers. ...
... together for a conference on drink and drug abuse in ... going to be a year long deliberation on the issue. ... the parliament's corporate body to ascertain the key problems facing ... and international organizations. ,Scotland's Futures Forum, in a ...
... virus has struck in Northern Thailand; health officials have confirmed ... than 100 ducks in Phitsanulok province.// ,Nirand ... Development said, "We have found the H5N1 virus in the ... area to be killed." ,The place in question ...
Cached Medicine News:Health News:Chiropractic Care May Help Children With Learning Disorders 2Health News:Madhya Pradesh Has India's Most Malnourished Kids 2Health News:Madhya Pradesh Has India's Most Malnourished Kids 3Health News:Tomato and Broccoli Combo may Help Fight Prostate Cancer 2
0.5 mm angled tip. Round knurled handle with dull finish. Tip angle: 130 degrees....
0.2 mm, 90o angled tip. Flat smooth handle with polished finish....
Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
... was designed to lift and reposition a ... postoperatively. The curved chisel end is designed ... edge and then cleanly cut through the ... and reposition the flap after the laser ...
Medicine Products: